Varian Medical Systems (VAR) - FREE Research Report

Verhoef Clarence R who is SVP, Finance, Corp Controller at Varian Medical Systems sold 1,297 shares at $76.13 on Dec. 24, 2013. Following this transaction, the SVP, Finance, Corp Controller owned 1,908 shares meaning that the stake was reduced by 40.47% with the 1,297-share transaction.

The shares most recently traded at $76.78, up $0.65, or 0.84% since the insider transaction. Historical insider transactions for Varian Medical Systems go as follows:

  • 4-Week # shares sold: 14,229
  • 12-Week # shares sold: 17,201
  • 24-Week # shares sold: 24,250

The average volume for Varian Medical Systems has been 776,100 shares per day over the past 30 days. Varian Medical Systems has a market cap of $8.1 billion and is part of the health care sector and health services industry. Shares are up 9.24% year-to-date as of the close of trading on Tuesday.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. The company has a P/E ratio of 19.3. Currently there are 6 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VAR - FREE

TheStreet Quant Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Varian Medical Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Britain's Prudential Sells U.S. Broker-Dealer Network to LPL Financial

LPL Financial (LPLA) Stock Retreats, JPMorgan Downgrades

Analysts' Actions -- Barracuda, Lam Research, Mohawk, Marvell and More

LPL Financial (LPLA) Stock Climbs on Potential Sale

Analysts' Actions -- Hormel, L Brands, LPL Financial, Madison Square Garden and More